Journal Home
Search for

Volume 15, Issue 10, Pages 1271-1276 (October 2009)


View previous. 11 of 22 View next.

Osteochondroma after Hematopoietic Stem Cell Transplantation in Childhood. An Italian Study on Behalf of the AIEOP-HSCT Group

AIEOP-HSCT GroupMaura Faraci1Corresponding Author Informationemail address, Francesca Bagnasco2, Paola Corti3, Chiara Messina4, Franca Fagioli5, Marta Podda6, Arcangelo Prete7, Desirè Caselli8, Edoardo Lanino1, Giorgio Dini1, Roberto Rondelli7, Riccardo Haupt2

Received 6 April 2009; accepted 4 June 2009. published online 10 August 2009.

A retrospective study was conducted among Italian children treated with hematopoietic stem cell transplant (HSCT) to evaluate the incidence and risk factors in the development of osteochondroma (OC). OC occurred in 27 patients who received autologous or allogeneic HSCT. The estimated 5-, 10-, and 15-year cumulative risk of developing OC was 0.5%, 3.2%, and 6.1%, respectively. Analysis of cumulative risk stratified by the various risk factors revealed that male sex (P=.026), autologous HSCT (P=.001), age at HSCT (≤3 years) (P < .0001), and total body irradiation (TBI) (P <.0001) significantly affected the risk of OC. Multivariate analysis, restricted only to tumor types with at least 1 case of OC, showed that earlier age at HSCT (P =.0004) and TBI (P < .0001) were the only factors that were significantly associated with OC.

1 Department of Hematology-Oncology, Bone Marrow Transplant Unit, G. Gaslini Children's Hospital, Genova, Italy

2 Epidemiology and Biostatistics Section, Scientific Directorate, G. Gaslini Children's Hospital, Genova, Italy

3 Bone Marrow Unit, Clinic of Pediatrics, University of Milano Bicocca, San Gerardo Hospital, Monza, Italy

4 Clinic of Pediatric Hematology Oncology, Department of Pediatrics, University of Padova, Padova, Italy

5 Clinic of Pediatric Hematology Oncology, Department of Pediatrics, Regina Margherita Pediatric Hospital, Torino, Italy

6 Pediatric Oncology Unit, Foundation IRCSS, Institute National of Tumors, Milano, Italy

7 Department of Pediatrics, University of Bologna, Sant'Orsola Hospital, Bologna, Italy

8 DAI, Oncology-Oncology and Home Care, AUO Mayer, Firenze, Italy

Corresponding Author InformationCorrespondence and reprint requests: Maura Faraci, MD, Department of Oncology/Oncology, Stem Cell Transplantation Section, G. Gaslini Children's Hospital, Largo G. Gaslini, 5; 16147 Genova, Italy.

 Financial disclosure: See Acknowledgments on page 1276.

PII: S1083-8791(09)00275-4

doi:10.1016/j.bbmt.2009.06.003


View previous. 11 of 22 View next.